Human Tissue and Genomics Core
Human Tissue and Genomics Core
批准号:
8604569
负责人:
Hans H. Herfarth
金额:
$25.4万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAnimal ExperimentationAnimal ModelAutomobile DrivingBioinformaticsBiologicalBiological AssayBiopsyCellsChromatinClinicalDNADataDatabasesDiseaseEnteralExcisionExperimental ModelsFamily memberFormaldehydeFreezingGene ExpressionGene Expression RegulationGene TargetingGenesGenomicsGoalsHumanImmuneImmunophenotypingIndividualInflammatory Bowel DiseasesInflammatory ResponseInflammatory disease of the intestineInterleukin-10Interleukin-12IntestinesLinkMediatingMicrobeModelingMolecularOperative Surgical ProceduresPathogenesisPatientsPatternPeripheral Blood Mononuclear CellPhenotypePlayPopulationProcessProteinsRNARegulator GenesRegulatory ElementResearch InfrastructureResearch PersonnelResourcesRoleSamplingSerumSingle Nucleotide PolymorphismTestingTissue BankingTissue BanksTissueschromatin immunoprecipitationclinical phenotypedisease phenotypedisorder controlfunctional genomicsgenome wide association studyhuman diseasehuman tissueinterestmeetingsmicroorganism interactionnew technologytranscription factor
中文摘要
核心B
核心B的主要目标是为单个项目提供肠道组织、分离的细胞群和
来自临床特征的IBD患者和健康对照的功能基因组信息。这个核心将
克服广泛承认的动物模型使用障碍-指导动物研究以解决
可以直接翻译成人类IBD的问题。数据和组织库与新技术
通过这个核心的开发将使研究人员有机会将分子发现与
人类疾病的典范物种。核心B将利用北卡罗来纳大学的大量现有资源和专业知识。
在获取和处理手术切除和肠道活组织检查方面有一个既定的基础设施。
这个
英文摘要
Core B
The primary goal of Core B is to provide individual projects with intestinal tissue, isolated cell populations, and
functional genomic information from clinically characterized IBD patients and healthy controls. This core will
overcome a widely acknowledged roadblock in the use of animal models - directing animal research to address
questions that will be directly translatable to human IBD. The data and tissue banks and novel technologies
developed through this core will allow investigators the opportunity to correlate molecular findings across
model species to human diseases. Core B will leverage substantial existing resources and expertise at UNC.
There is an established infrastructure for obtaining and processing surgical resections and intestinal biopsies.
The
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MEthotrexate Response in Treatment of UC - MERIT-UC
-
批准号:8703089
-
项目类别:
-
资助金额:$154.89万
-
财政年份:2011
-
负责人:Hans H. Herfarth
-
依托单位:
MEthotrexate Response in Treatment of UC - MERIT-UC
-
批准号:8499298
-
项目类别:
-
资助金额:$157.14万
-
财政年份:2011
-
负责人:Hans H. Herfarth
-
依托单位:
MEthotrexate Response in Treatment of UC - MERIT-UC
-
批准号:8916675
-
项目类别:
-
资助金额:$154.37万
-
财政年份:2011
-
负责人:Hans H. Herfarth
-
依托单位:
MEthotrexate Response in Treatment of UC - MERIT-UC
-
批准号:8316407
-
项目类别:
-
资助金额:$167.05万
-
财政年份:2011
-
负责人:Hans H. Herfarth
-
依托单位:
MEthotrexate Response in Treatment of UC - MERIT-UC
-
批准号:8163797
-
项目类别:
-
资助金额:$182.93万
-
财政年份:2011
-
负责人:Hans H. Herfarth
-
依托单位:
Methotrexate Response In Treatment of UC
-
批准号:7740248
-
项目类别:
-
资助金额:$38.81万
-
财政年份:2009
-
负责人:Hans H. Herfarth
-
依托单位:
CLINICAL TRIAL: CIPROFLOXACIN FOR PROPHYLACTIC PREVENTION OF POSTOPERATIVE ENDOS
-
批准号:7716910
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2008
-
负责人:Hans H. Herfarth
-
依托单位:
Pilot study on the safety and efficacy of ciprofloxacin for prophylactic preventi
-
批准号:7357376
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2007
-
负责人:Hans H. Herfarth
-
依托单位:
Pilot study on the safety and efficacy of ciprofloxacin for prophylactic preventi
-
批准号:7500702
-
项目类别:
-
资助金额:$21.46万
-
财政年份:2007
-
负责人:Hans H. Herfarth
-
依托单位:
Human Tissue and Genomics Core
-
批准号:9091533
-
项目类别:
-
资助金额:$29.04万
-
财政年份:--
-
负责人:Hans H. Herfarth
-
依托单位:
Human Tissue and Genomics Core
-
批准号:8890149
-
项目类别:
-
资助金额:$29.04万
-
财政年份:--
-
负责人:Hans H. Herfarth
-
依托单位:
Human Tissue and Genomics Core
-
批准号:8737243
-
项目类别:
-
资助金额:$29.04万
-
财政年份:--
-
负责人:Hans H. Herfarth
-
依托单位:
海外基金